Insights · Insights

Due Diligence, Regulation and Consumer Insight in Korea

VELOR 에디터 · 2026.8.15 · 7 min read
TL;DRKorean commercial diligence fails most often on channel reality and customer concentration, not financials. Regulatory pathways under MFDS and sector agencies rarely map onto FDA or EMA equivalents, and local testing requirements drive timelines. Consumer category dynamics — beauty and food especially — move faster than any published report cycle.

Three recurring needs bring foreign companies to Korean expertise: verifying what a target or partner actually is, understanding a regulatory pathway, and reading a consumer category correctly. Each fails in a characteristic way.

Commercial due diligence

Financial diligence in Korea is broadly conventional. Commercial diligence is where surprises live.

The questions that most often change a deal view:

Customer concentration and true relationship depth. A supplier with an impressive customer list may be a qualified secondary source with minimal allocated volume. Someone on the procurement side of that customer can tell you which it is, usually in one conversation.

Channel reality. Reported distribution coverage and effective shelf presence diverge frequently. Category practitioners know which listings are active and which are nominal.

Technology claims. A claimed capability that has not passed a Korean customer's qualification process is a different asset from one that has. Engineers who have run those qualifications can assess plausibility quickly.

Key-person dependency. In Korean mid-market companies, commercial relationships often sit with individuals rather than institutions. Understanding whether relationships survive a transaction is a core diligence question, and one that rarely appears in a data room.

Regulatory standing. Pending inspections, remediation history, and licence conditions may be visible to industry practitioners well before they surface in disclosure.

Competitive intelligence, done legitimately

There is a firm line between market intelligence and misappropriation. Legitimate work relies on practitioners describing how a market functions, what buyers weigh, how competitors are generally positioned, and where structural constraints exist — drawn from professional experience, not from confidential documents.

Any provider that offers current confidential competitor data is creating legal exposure for you, not delivering value. Screening for conflicts, excluding material non-public information, and documenting conduct terms are baseline requirements.

Regulatory pathways

Korean regulatory processes have their own logic, and mapping them onto FDA or EMA assumptions produces schedule errors.

Pharmaceuticals and medical devices fall under MFDS. Clinical data acceptance, local trial requirements, and device classification frequently differ from other jurisdictions. Reimbursement is a separate process from approval, and for many products the reimbursement pathway determines commercial viability more than approval itself.

Cosmetics operate under a distinct framework, with functional cosmetics carrying additional requirements and ingredient rules that do not align with EU or US lists.

Food and health functional food involves separate categories, with health functional food claims requiring specific substantiation.

Electrical and consumer goods require KC certification, with local testing that cannot always be waived by foreign test reports.

The consistent theme: local testing requirements and documentation formats drive timelines more than review queues. A regulatory affairs professional who has filed in your specific category is the most efficient way to get a realistic schedule.

Consumer categories

Korean consumer markets move quickly and are heavily influenced by channel structure and platform dynamics. Two categories draw persistent foreign interest.

Beauty. Korean beauty's export success has made it a reference market, but the domestic category is fragmented, trend cycles are short, and channel economics differ sharply between olive-type retail, e-commerce platforms, and duty free. Manufacturing capacity is concentrated in a few large ODM players, which shapes both cost structure and speed to market for new brands.

Food. Korean food exports have grown rapidly, but domestic and export dynamics are different businesses. Retail listing processes, distributor structures, and shelf-life and labelling requirements each carry country-specific detail.

For both, published reports lag the market. Someone currently or recently operating in the category will describe channel economics and buyer behaviour more accurately than any available report.

Choosing the right profile

Your questionThe profile that answers it
Is this target's customer relationship real?Procurement lead at that customer type
Will this product's claims survive qualification?Engineer who has run those qualifications
How long will approval actually take?Regulatory affairs professional in that category
Why is this category behaving this way?Category manager or brand operator, recent
Where are the supply chain dependencies?Procurement or quality professional

Working with VELOR

VELOR matches companies with Korean professionals holding twenty or more years of experience in a specific industry and function — including regulatory affairs, procurement, quality and category management.

The service is free while we build our expert base, and we take no commission on introductions. Diligence and regulatory engagements are scoped with explicit confidentiality boundaries before any conversation takes place.

Frequently asked questions

What does commercial due diligence in Korea need to verify?

Customer concentration and true relationship depth, effective channel presence versus reported coverage, whether technology claims have passed Korean customer qualification, key-person dependency in commercial relationships, and regulatory standing including remediation history. Financial diligence is conventional; these operational questions are where deal views change.

How does Korean regulatory approval differ from FDA or EMA?

Korean pathways under MFDS and sector agencies have their own classification logic, local testing requirements, and documentation formats that foreign test reports cannot always replace. Reimbursement is also a separate process from approval, and for many products it determines commercial viability more than approval does.

Is competitive intelligence in Korea legal?

Legitimate competitive intelligence relies on practitioners describing how a market functions and how competitors are generally positioned, drawn from professional experience. It excludes confidential documents and material non-public information. Any provider offering current confidential competitor data is creating legal exposure rather than delivering value.

See how far your plan holds up — free 30-second AI assessment.

Tell us what you need to find out — free diagnostic
← Back to VELOR for global clients